Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeuSTART2: High-Dose Lovastatin in Acute Ischemic Stroke
NCT01976936Phase 2Completed
- Sponsor
- Columbia University
- Start
- Feb 2009
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lovastatin in ischemic stroke (3 arms), sponsored by Columbia University. Primary endpoint: Total Number of Participants With an Increase in Liver Function Tests at 7 days. Started Feb 2009; status: completed.
02
Drugs
lovastatin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01976936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01976936.